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Autosomal recessive primary microcephaly (MCPH) is a neurodevelopmental disorder. It is characterized by two
principal features, microcephaly present at birth and nonprogressive mental retardation. The microcephaly is the
consequence of a small but architecturally normal brain, and it is the cerebral cortex that shows the greatest size
reduction. There are at least seven MCPH loci, and four of the genes have been identified: MCPH1, encoding
Microcephalin; MCPH3, encoding CDK5RAP2; MCPH5, encoding ASPM; and MCPH6, encoding CENPJ. These
findings are starting to have an impact on the clinical management of families affected with MCPH. Present data
suggest that MCPH is the consequence of deficient neurogenesis within the neurogenic epithelium. Evolutionary
interest in MCPH has been sparked by the suggestion that changes in the MCPH genes might also be responsible
for the increase in brain size during human evolution. Indeed, evolutionary analyses of Microcephalin and ASPM
reveal evidence for positive selection during human and great ape evolution. So an understanding of this rare genetic
disorder may offer us significant insights into neurogenic mitosis and the evolution of the most striking differences
between us and our closest living relatives: brain size and cognitive ability.
Introduction
The aim of this review is to summarize the recent findings
in autosomal recessive primary microcephaly (MCPH).
First, the clinical features of the disorder are discussed,
especially that “microcephaly” is the finding of a reduced
head circumference (HC) and that MCPH is but one of
many conditions in which the principal features are “mi-
crocephaly and mental retardation. Second, we review
the molecular genetic findings for the six known reces-
sive loci, for which four of the genes have been discov-
ered. Thirdly, we present the evidence that MCPH is the
consequence of deficient mitosis in neural precursors.
And finally, we discuss the role that MCPH genes might
have played during the evolution of the human brain,
which is approximately three times larger than that ex-
pected for a primate of our body size.
Clinical Features of MCPH
Microcephaly and HC
The term “microcephaly” refers to a clinical finding:
an HC significantly less than expected for an individual’s
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age and sex (Warkany 1981; Aicardi 1998). HC is used
as a surrogate measurement of brain size; however, it is
only imperfectly correlated with brain volume. Other
methods have been used (e.g., volumetric nuclear mag-
netic resonance [NMR] scanning), but HC remains the
common, simple method for evaluating gross brain size
(Aicardi 1998), although it needs to be accurately mea-
sured and charted relative to age and sex (Nellhaus
1968; Sher and Brown 1975; Babson and Benda 1976;
Sells 1977; Gross et al. 1983; Roche et al. 1987). An
HC of three standard deviations below the mean (3
SD) is usually the cut-off for defining microcephaly (Ross
and Frias 1977; Baraitser 1990). Importantly, micro-
cephaly is strongly correlated with mental retardation
(Warkany 1981; Gross et al. 1983; Dolk 1991). Indi-
viduals with an HC of 3 SD and normal intelligence
are occasionally reported, but individuals with an HC
of 4 SD or less and normal intelligence are very rare
(Teebi et al. 1987).
Microcephaly is divided into primary microcephaly,
which is present at birth, and secondary microcephaly,
which develops postnatally (Woods 2004). The crucial
difference between these groupings is that primary mi-
crocephaly is usually a static developmental anomaly,
whereas secondary microcephaly indicates a progressive
neurodegenerative condition (Qazi and Reed 1973; Op-
itz and Holt 1992; Dobyns 2002; Rosenberg et al. 2002).
There are many nongenetic and genetic causes of “pri-
mary microcephaly with mental retardation,” such as
congenital infection with toxoplasma, maternal alcohol
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overconsumption during pregnancy, and Rubenstein
Taybi syndrome, all of which must be excluded before
the diagnosis of MCPH is considered (Cowie 1960; Win-
ter and Baraitser 2003).
Definition of MCPH as a Phenotype
“True microcephaly,” “microcephaly vera,” and “au-
tosomal recessive primary microcephaly” are terms in
the literature that were probably all intended to describe
the same phenotype. In “true microcephaly,” the sloping
forehead was a defining feature; however, it is not seen
in all cases of MCPH (Bundey 1997; Roberts at al.
2002). Over time, “microcephaly vera” has come to in-
clude the condition of any child with congenital micro-
cephaly accompanied by a range of neurological fea-
tures, and hence it has lost specificity as a diagnosis.
This led to the introduction of a new diagnostic label,
“autosomal recessive primary microcephaly,” shortened
to “MCPH” (MIM #251200) (Jackson et al. 1998).
The initial defining clinical features of MCPH in the
studies by Jackson et al. (2002) and Roberts et al. (2002)
were:
1. Congenital microcephaly at least 4 SD below age
and sex means.
2. Mental retardation but no other neurological find-
ing, such as spasticity, seizures, or progressive cog-
nitive decline.
3. Normal height and weight, appearance, and results
on chromosome analysis and brain scan.
MCPH is a disorder of fetal brain growth. The timing
of the reduction in growth has been elucidated by ul-
trasound of affected pregnancies. Normal head mea-
surements are found up to 20 wk of gestation, whereas
a decreased HC is seen by 32 wk (C.G.W., personal
observation). After birth, HC lies between 4 and 12
SD (Roberts et al. 2002). The relative degree of micro-
cephaly does not vary throughout life, and within a fam-
ily HC usually does not vary by 12 SD between affected
individuals (Roberts et al. 2002). NMR and CAT scans
of the brain show that MCPH causes a central nervous
system of reduced size, with the greatest effect on the
cerebral cortex (Bond et al. 2002). MCPH is associated
with a simplification of the cerebral cortical gyral pattern
and a slight reduction in the volume of the white matter,
consistent with the small size of the brain (Barkovich et
al. 2001). In general, the architecture of the CNS is nor-
mal, with no evidence of a neuronal migration defect
(Bond et al. 2002).
Individuals with MCPH are all mentally retarded, but
the retardation is usually only of mild to moderate se-
verity (Roberts et al. 2002). There is no evidence of
progressive cognitive decline or of any motor deficit.
Early milestones such as alertness, smiling to parents,
and head control are often normal. Later motor and
social milestones are mildly delayed, but speech devel-
opment is consistently delayed. As teenagers, children
with MCPH have good fine motor control, balance, and
grace in movements. They achieve well in sports, com-
pared with other mentally retarded children, and often
have a “happy affect.” Individuals with MCPH tend to
be well behaved and are “biddable”—that is, they are
compliant with instruction and can be taught skills of
daily living, common-sense safety, and some reading and
writing (Ross and Frias 1977; Roberts et al. 2002).
Subsequent to MCPH gene discovery, genotype/phe-
notype studies showed that the original MCPH diag-
nostic criteria required revision. Whereas the original
definition excluded seizures, height reduction, and ab-
normal cytogenetic findings, these features have now
been reported in some cases of MCPH, and the diagnosis
of MCPH is no longer excluded by their presence. Spe-
cific genotype-phenotype correlations have been made
for individuals with MCPH1 mutations. These individ-
uals may have a reduction in height, although it is not
as marked as the degree of microcephaly (Neitzel et al.
2002; Trimborn et al. 2004). In one MCPH1 family, a
small number of periventricular neuronal heterotopias
(groups of neurons in an abnormal position within the
brain) were found—which is indicative of abnormal neu-
ronal migration (Trimborn et al. 2004). Periventricular
neuronal heterotopias were not reported in the original
families used to link and identify the MCPH1 gene, so
their relative incidence is unknown (Jackson et al. 2002).
MCPH1 mutations are also consistently associated with
an increased proportion of cells with premature chro-
mosome condensation leading to a prophaselike ap-
pearance seen on cytogenetic analysis (see below).
The current clinical definition of MCPH is as follows:
1. Congenital microcephaly, with HC at least 4 SD
below age and sex means.
2. Mental retardation but no other neurological find-
ing, such as spasticity, or progressive cognitive decline.
Fits are unusual but do not exclude the diagnosis.
3. For the majority of people with MCPH, normal
height, weight, appearance, chromosome analysis, and
brain scan are reported. For people with MCPH1 mu-
tations, a reduction in height may be found, but the HC
will always be significantly more reduced than height;
on NMR scan, some MCPH1 patients show evidence of
periventricular neuronal heterotopias suggestive of neu-
ronal migration defects; and cytogenetic analysis may
indicate an increased proportion of prophaselike cells.
Incidence of MCPH
Prior to the discovery of MCPH genes, autosomal re-
cessive microcephaly was reported to have an incidence
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Table 1
MCPH Loci
Locus
Autosomal
Localization Linkage Reference Gene Ethnicity
MCPH1 8p22-pter Jackson et al. 1998 Microcephalin Northern Pakistani
MCPH2 19q13.1-13.2 Roberts et al. 1999 Unknown Northern Pakistani and Indian
MCPH3 9q34 Moynihan et al. 2000 CDK5RAP2 Northern Pakistani
MCPH4 15q15-q21 Jamieson et al. 1999 Unknown Moroccan
MCPH5 1q31 Pattison et al. 2000; Jamieson
et al. 2000
ASPM Northern Pakistani, Turkish, Jordanian, Dutch,
Saudi Arabian, Yemeni, and Indian
MCPH6 13q12.2 Leal et al. 2003 CENPJ Northern Pakistani and Brazilian
NOTE.—The known MCPH loci are listed in chronological order of discovery. For each locus, the autosomal location is given,
with the appropriate reference, the name of the gene (if known), and the ethnicities of the individuals in whom a mutation has
been reported.
of 1/30,000 in Japan, 1/250,000 in Holland, and 1/
2,000,000 in Scotland (Komai et al. 1955; Van den
Bosch 1959; Tolmie et al. 1987). More-recent studies
have not been performed; however, MCPH seems rarer
in whites than in Asian and Arab populations where
consanguineous marriage is practiced. Our anecdotal ex-
perience in the Yorkshire region of Britain is a white
MCPH incidence of 1 per million compared to 1/10,000
in those originating from northern Pakistan. An in-
creased incidence of autosomal recessive diseases in con-
sanguineous populations is expected on theoretical
grounds and has been observed (Freire-Maia 1990; Bun-
dey and Alam 1993; Tuncbilek 2001). Given the number
of MCPH genes and mutations found in the Pakistani
population (see below), the high incidence of MCPH
probably reflects the effects of consanguinity and not a
founder effect.
Inheritance of Primary Microcephaly
Prior to the discovery of MCPH genes, “true micro-
cephaly” or “microcephaly vera” had been considered
to be inherited as an autosomal recessive disorder
(Kloepfer et al. 1964; Bundey 1997). This hypothesis
was based on the reports of pedigrees with multiple af-
fected siblings but unaffected parents, frequent parental
consanguinity, and segregation ratios that suggested a
large proportion of primary microcephaly, particularly
in consanguineous populations, is caused by recessive
genes (Bo¨o¨k et al. 1953; Komai et al. 1955; Van den
Bosch 1959; Sujatha et al. 1989). Although the expected
recurrence risk for autosomal recessive traits is 1 in 4,
the empiric recurrence risk for a nonconsanguineous
couple who have had one child with a diagnosis of
MCPH has been calculated as 1 in 5 if detailed chro-
mosome studies and neuroimaging yield normal results
(Tolmie et al. 1987). It has been suggested that there
may be a phenotype in heterozygous carriers of MCPH
mutations, because of an increased frequency of intel-
lectual impairment in parents of individuals with reces-
sive microcephaly (Kloepfer et al. 1964; Qazi and Reed
1975). However, this has not been a consistent finding,
and this matter awaits reassessment (Van den Bosch
1959; Roberts et al. 2002).
Molecular Genetics of MCPH
Linkage and Heterogeneity
MCPH was expected to exhibit genetic heterogeneity,
because of its broad clinical phenotype (Cowie 1960).
Six loci have been identified to date (MCPH1–MCPH6;
see table 1) (Jackson et al. 1998; Jamieson et al. 1999,
2000; Roberts et al. 1999, 2002; Moynihan et al. 2000;
Pattison et al. 2000; Leal et al. 2003). Each recessive
locus was initially mapped in a large consanguineous
family by autozygosity mapping techniques, using panels
of ∼400 polymorphic autosomal microsatellite markers
spread throughout the human genome at a distance of
∼12 cM (Lander and Botstein 1987; Mueller and Bishop
1993).
Four of the six loci (MCPH1–MCPH3 and MCPH5)
were discovered in families of northern Pakistani origin,
with two loci (MCPH1 and MCPH3) remaining exclu-
sive to this population.
MCPH heterogeneity studies have been performed in
a northern Pakistani population and MCPH5 was iden-
tified as the most common locus, accounting for linkage
of nearly half of the amassed families (24/56 families)
(Roberts et al. 2002). MCPH2 accounted for 10 families
(14%); MCPH1 and MCPH3 were each associated with
two families (4%), whereas MCPH4 linkage has not
been found in the Pakistani population. MCPH6 had
not been identified at the time of the heterogeneity in-
vestigation; however, subsequently this locus has been
linked to families of northern Pakistani origin (Bond et
al. 2005). MCPH2, MCPH5, and MCPH6 are repre-
sented in multiple populations (Jamieson et al. 2000;
Pattison et al. 2000; Bond et al. 2002, 2003; Leal et al.
2003, Kumar et al. 2004). Further MCPH loci await
discovery, as 18/56 northern Pakistani families and
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5/9 Indian families show no evidence of linkage to the
known loci (Roberts et al. 2002; Kumar et al. 2004).
Genes
Positional cloning strategies have been employed to
identify causative genes at four loci (fig. 1 and table 1):
MCPH1 (Jackson et al. 2002), MCPH5 (Bond et al.
2002), MCPH3 (Bond et al. 2005), and MCPH6 (Bond
et al. 2005).
MCPH1/Microcephalin.—Using ancestral haplotyp-
ing of novel microsatellite markers, Jackson and col-
leagues further refined the MCPH1 region from 13 cM
to 2.1 Mb before commencing candidate gene sequenc-
ing. In two consanguineous families of northern Pakis-
tani origin, a single homozygous 74CrG (S25X) non-
sense mutation was identified in the second exon of a
2,505-nucleotide, 14-exon uncharacterized gene named
“Microcephalin” (Jackson et al. 2002) The mutation
segregated correctly within the families and was not pre-
sent in 1200 population-matched control alleles. Micro-
cephalin is expressed in fetal brain, fetal liver, and fetal
kidney at similar levels and is expressed at low levels in
other fetal and adult tissues. Tissue in situ hybridization
studies of Microcephalin mRNA in mouse fetal sections
identified regions of Microcephalin expression in the de-
veloping forebrain during the period of neurogenesis.
MCPH5/ASPM.—The most common cause of MCPH
is homozygous mutations in the MCPH5 gene, Abnor-
mal Spindle–like, Microcephaly associated (Drosophila)
(ASPM) (Bond et al. 2002, 2003; Kumar et al. 2004;
Pichon et al. 2004; Shen et al., in press). ASPM is a large
gene with 28 exons and a 10.4-kb ORF, and its name
is derived from the Drosophila gene abnormal spindles.
The 24 published ASPM mutations comprise nonsense
mutations, deletions of 1–7 base pairs, a breakpoint
translocation, and intronic splice-donor point mutations
(Bond et al. 2002, 2003; Kumar et al. 2004; Pichon et
al. 2004). The mutations are distributed throughout the
gene and are all predicted to produce truncated protein
products ranging in size from 116 amino acids (R117X)
to 3,357 amino acids (K3328fsX29). There is no cor-
relation between the position of the mutation in the gene
and the degree of microcephaly or mental retardation
(Bond et al. 2002, 2003). This may indicate that the
common mechanism of action of ASPM mutation is non-
sense-mediated decay (Cartegni et al. 2002). Investiga-
tion of the fetal expression pattern of Aspm mRNA in
mouse brain revealed expression at sites of active neu-
rogenesis in the neuroepithelium (Bond et al. 2002).
Postnatally, Aspm expression decreases with the com-
pletion of neurogenesis and upregulation of gliogenesis
in the cortex. This expression pattern indicates that
Aspm is involved in neuron rather than glia production.
Thus, the neuronal reduction associated with MCPH
due to ASPM mutations is compatible with the expres-
sion pattern of Aspm in mouse brain.
It has been suggested that a second gene causing
MCPH exists at the MCPH5 locus, as mapping studies
in five Jordanian and Dutch families linked the families
to the MCPH5 locus but excluded the genetic region
containing ASPM (Wallerman et al. 2003). If this is the
case, it must be a rare cause of MCPH, since all MCPH5
linked Pakistani families have mutations in ASPM and
since ASPM mutations in the Dutch and Jordanian pop-
ulations have been identified (Bond et al. 2002, 2003)
MCPH3/CDK5RAP2.—The MCPH3 locus was refined
from 12 cM to 2.2 Mb by the identification and sub-
sequent microsatellite screening of a second family of
northern Pakistani origin that shows linkage and with
multiple affected members (Moynihan et al. 2000;
Bond et al. 2005). A 34-exon candidate gene, Cyclin
Dependent Kinase 5 Regulatory Associated protein 2
(CDK5RAP2) was sequenced in the families. A homo-
zygous 243TrA (S81X) nonsense mutation and an in-
tronic mutation 15 bases prior to the normal splice-
acceptor sequence IVS26-15ArG (E385fsX4) were
identified. Both mutations segregated with the disease
within the families and were not present in 1380 control
alleles. The intronic mutation creates a new, superior
splice-acceptor site for exon 27, leading to the transla-
tion of 4 amino acids before a termination codon is
reached. Gene expression of Cdk5rap2 in murine sagittal
sections was highest in the brain and the spinal cord,
particularly in the neuroepithelium of the frontal cortex
(Bond et al. 2005).
MCPH6/CENPJ.—The 6-Mb MCPH6 region was re-
fined by the use of novel polymorphic microsatellite
markers that were genotyped in the original Brazilian
family used to map the locus and in two additional
northern Pakistani multiply-affected consanguineous
families (Leal et al. 2003; Bond et al. 2005). This facil-
itated the reduction of the locus to 3.1 Mb and enabled
the selection of a candidate gene, Centromere associated
Protein J (CENPJ, also known as “CPAP,” for centro-
somal protein 4.1- associated protein), in which two
homozygous mutations were identified: the frameshift
mutation 17delC in exon 2 (T6fsX3), in two pedi-
grees, and the missense mutation 3704ArT in exon
16 (E1235V), in one pedigree. 3704ArT is the only
MCPH mutation described to date that is not predicted
to result in a protein truncation. The E1235V mutation
occurs in a highly conserved Tcp10 binding domain,
which is involved in binding to the protein 4.1R-135,
but how it leads to a functional null allele is unknown
(fig. 1d) (Hung et al. 2004).
Mitosis and MCPH
Microcephalin, Cell Cycle, and DNA Repair.—The
835-aa Microcephalin gene product is predicted to con-
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tain three BRCA1 C-terminal domains (BRCT domains),
with the S25X protein-truncating mutation occurring in
the first of these domains (fig. 1a). Other proteins con-
taining BRCT domains have roles in cell-cycle control
and DNA repair (Hyton et al. 2000), and a loss of DNA
repair genes can lead to apoptosis during neurogenesis
(Mochida and Walsh 2001). This led Jackson and col-
leagues to hypothesize that Microcephalin may have a
function in DNA repair or cell-cycle control and that
the phenotype of MCPH might result from perturbation
of normal cell-cycle regulation in neuronal progenitors
(Jackson et al. 2002).
Two potential roles of Microcephalin have emerged,
one on the control of cell-cycle timing and the other of
DNA repair following ionizing radiation damage (Trim-
born et al. 2004; Xu et al. 2004). A novel autosomal
recessive disorder was described that was characterized
by premature chromosome condensation (PCC) in sib-
lings from a consanguineous family exhibiting micro-
cephaly, growth retardation, and mental retardation
(Neitzel et al. 2002). Patient cell preparations exhibited
a high proportion of prophaselike cells (7%–17%), sig-
nifying early onset of chromosome condensation. The
disorder was found to result from a 427insA mutation
in Microcephalin (Trimborn et al. 2004). MCPH1 pri-
mary microcephaly shares this cellular phenotype of
PCC, and it can also be recapitulated by small-interfer-
ing-RNA–mediated depletion of Microcephalin (Trim-
born et al. 2004). Experimental depletion of Micro-
cephalin also impairs radiation-induced intra-S-phase
and G2/M cell-cycle checkpoints by decreasing the levels
of BRCA1 and Checkpoint kinase 1 (Xu et al. 2004).
MCPH may therefore result from a perturbation of the
cell cycle in neurogenesis (Trimborn et al. 2004).
ASPM and the Spindle Pole Body.—Bioinformatics
analyses suggest that the 3,477-aa human ASPM protein
contains a putative amino terminal microtubule binding
domain (Saunders et al. 1997); at least one calponin
homology domain; 74 isoleucine-glutamine (IQ) do-
mains, which potentially bind calmodulin (Craig and
Norbury 1998; Bond et al. 2002); and a carboxy ter-
minal region of no known function (fig. 1b).
Asp, the probable ortholog of ASPM in Drosophila,
is essential for organization and bundling of microtu-
bules at the spindle poles and has been shown to be
necessary for the proper formation of a central mitotic
spindle in mitosis and meiosis (Ripoll et al. 1985; Gon-
zalez et al. 1990; Avides and Glover 1999; Avides et al.
2001; Wakefield et al. 2001; Riparbelli et al. 2001). This
role is supported by results from immunofluorescence
studies, which have shown wild-type Asp to be distrib-
uted throughout the cytoplasm in interphase but to lo-
calize to the spindle poles during mitosis when the bi-
polar spindle is formed (Saunders et al. 1997; Wakefield
et al. 2001; Riparbelli et al. 2002). During late anaphase
and telophase, when the spindle begins to disassemble,
Asp relocates to the minus ends of the central spindle
microtubules, where it remains until the central spindle
has broken down (Saunders et al. 1997; Avides and
Glover 1999; Wakefield et al. 2001).
CDK5RAP2, CENPJ, and the Centrosome.—Human
CDK5RAP2 and CENPJ are also centrosomal proteins,
being localized to the centrosomes in interphase and to
the spindle poles during mitosis (Hung et al. 2000;
Bond et al. 2005). The probable Drosophila ortholog
of CDK5RAP2, centrosomin (cnn), interacts with the
gamma tubulin ring complexes within the centrosome,
which are responsible for the production of the micro-
tubules forming the mitotic spindle (Li and Kaufman
1996; Megraw et al. 1999; Terada et al. 2003). Dro-
sophila cnn mutants exhibit a gross reduction in cell
number in the central and peripheral nervous systems
(Li and Kaufman 1996). CENPJ is known to interact
via a Tcp10 domain with nonerythrocyte 4.1 protein
135 splice variant (4.1R-135) (Hung et al. 2000). CENPJ
is associated with the g-tubulin ring complex (Hung et
al. 2004). In vitro evidence suggests that CENPJ might
be able to inhibit microtubule nucleation and to depo-
lymerize microtubules (Hung et al. 2004). Therefore,
CDK5RAP2 and CENPJ may be involved in the control
of the centrosomal production of microtubules during
neurogenic mitosis (Bond et al. 2005).
Neurodevelopmental Etiology of MCPH
All data to date suggest that MCPH is a primary disorder
of neurogenic mitosis and not one of neural migration,
neural apoptosis, or neural function. This is because all
four known MCPH genes are expressed in the neuroepi-
thelium, and phenotypic features and brain scans suggest
that MCPH patients have a small brain that functions
normally for its size.
The majority of neurons in the brain are thought to
originate from neuronal progenitors that are the pre-
dominant cells in the neuroepithelium, which line the
ventricles of the brain (Brand and Rakic 1979). Neural
progenitor cells have a specific pattern of mitotic activity
that was first delineated in fly neuroblasts: symmetric
cell divisions, which have mitotic spindles in the plane
of the neuroepithelium that yield two neural progenitor
cells, or asymmetric divisions, which occur when the
mitotic spindle is oriented perpendicular to the neuro-
epithelium, giving rise to one postmitotic neuron and
one progenitor cell (Doe and Bowerman 2001; Haydar
et al. 2003; Albertson and Doe 2003). Since the timing
of these two types of divisions during development is
likely to be crucial to the final number of neurons, it
has been proposed that changes in its regulation might
be responsible for some cortical disorders, like micro-
cephaly (Rakic 1988), and also for differences in brain
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Figure 2 Encephalization in primates. The relative encephalization of various primate species was mapped on a phylogeny of primates
(Goodman 1999). Data on brain weight and body weight was taken from Marino (1998) for apes, Old World monkeys, and New World
monkeys and from Stephan et al. (1981), as given by Clark et al. (2001), for prosimians. The encephalization quotient (i.e., the ratio of observed
brain weight to expected brain weight) is given in parentheses. The range is given when the data from several species are collapsed in the tree.
The expected brain weight was calculated from a linear regression on log transformed brain and body weights for the Marino data, excluding
humans ( ). Species showing at least a 1.4-fold–heavier brain than expected for theirbrain weightp 10 exp (0.6765# body weight 2.3406)
body weights are marked by rectangles.
size among different species (Rakic 1995). In mammals,
it has also been shown experimentally that larger brains
can result from increasing the number of neural pro-
genitor symmetric cell divisions (Kornack and Rakic
1998; Chen and Walsh 2003).
The function of MCPH genes during neurogenic mi-
tosis is unknown but is likely to be either (1) controlling
the expansion of the neural progenitor pool or (2) in-
volvement in the decision to switch from symmetric to
asymmetric cell division. The latter hypothesis is sup-
ported by Drosophila studies showing that homozygous
asp mutations result in metaphase arrest during asym-
metric cell division in larval brain and that cnn mutants
result in deficient asymmetric cell division in the male
germ line (Wakefield et al. 2001; Yamashita et al. 2003).
The cellular localization of three of the MCPH pro-
teins—CDK5RAP2, ASPM, and CENPJ—is known to
be centrosomal during mitosis. This suggests that the
centrosome is an organelle of great importance during
neurogenic mitosis.
MCPH, Brain Size, and Evolution
Brain size differs among animals mainly because animals
come in different sizes. In mammals, 190 % of variation
in brain weight can be explained by variation in body
weight (Jerison 1973). Outliers from this relationship
are of interest and if certain species or groups of species
have brain sizes that are larger than expected from their
body size (i.e., that are more “encephalized”), this is
usually interpreted as an adaptation of these species
(Harvey and Krebs 1990). No other species is as ence-
phalized as humans, which have an ∼5-fold larger brain
than expected for a mammal of their body size and an
∼3-fold larger brain than expected for an ape of their
body size. But increases in relative brain size have also
occurred in many other lineages among primates (see
fig. 2 and, e.g., Armstrong 1985; Stephan et al. 1988;
Marino 1998). Also notable are dolphins and related
whales, which are more encephalized than any primate
other than humans (Marino 1998). Fossil evidence sug-
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gests that encephalization increased several times during
human evolution, starting around 2 million years ago
and reaching its current state probably before the lineage
leading to modern humans split from that leading to
Neanderthals, ∼500,000 years ago (McHenry 1994). In-
terestingly, at least one reduction of relative brain size
occurred during the evolution of human species, as well:
a recently discovered species, Homo florensis, which
lived until 18,000 years ago on the Indonesian island
Flores, evolved probably from an ancestral Homo er-
ectus population but had a relative brain size substan-
tially lower than that in Homo erectus (Brown et al.
2004; Morwood et al. 2004).
MCPH is an intriguing disease from an evolutionary
standpoint, since it affects specifically the ratio of brain
size to body size and since the brain of affected indi-
viduals can be of comparable size to that of a chim-
panzee or gorilla (Bond et al. 2002; Jackson et al. 2002).
Maybe even more intriguing is that MCPH genes—as
discussed above—seem to play a role in the mitosis of
neuronal precursors and that this is the process that has
been hypothesized to be affected during the evolution
of larger brains (Rakic 1995). So, from a genetic point
of view, MCPH genes are excellent candidate genes for
gain-of-function mutations, because they can carry loss-
of-function mutations that affect the phenotype of in-
terest. With the discovery of the first two MCPH genes,
Microcephalin and ASPM, it has been possible to study
whether there is evidence for adaptive changes in these
genes and whether such changes correlate with changes
in relative brain size during evolution.
Studying Protein Evolution
When one compares the coding regions of a gene in
two species, one can find two types of differences: syn-
onymous differences, which do not change the encod-
ed protein sequence, and nonsynonymous differences,
which do. The ratio of synonymous differences to syn-
onymous sites (Ks) and the ratio of nonsynonymous dif-
ferences to nonsynonymous sites (Ka) can then be cal-
culated and compared (for reviews, see Yang and Bie-
lawski 2000; Hurst 2002; Fay and Wu 2003). If one
assumes that differences at synonymous sites do not have
any functional consequences (i.e., do not affect the fit-
ness of an organism), Ks can be regarded as an estimate
of the neutral mutation rate. So, if mutations at all non-
synonymous sites also have no functional consequence—
as is the case in a pseudogene—then Ka should be not
different from Ks, and the expected Ka/Ks ratio would
be 1. Since often mutations that change the protein se-
quence have negative consequences, these are not ob-
served as differences between two species and the Ka/Ks
ratio is !1. Sometimes, however, mutations at nonsy-
nonymous sites can have advantageous consequences
and these are then more likely to be observed between
two species. Therefore, a Ka/Ks ratio (significantly) larger
than one is interpreted as evidence for positive selection
in that gene. Of course, both of these effects can act on
a given gene, so that for example Ka/Ks can be smaller
than one if only a few nonsynonymous mutations have
been positively selected and many nonsynonymous sites
are under constraint. Consequently, if Ka/Ks ratios !1
differ (e.g., between two evolutionary lineages), this can
be due to a different amount of positive selection or to
a different amount of constraint in these two lineages.
One possible way to estimate the amount of constraint
is to analyze common polymorphisms within a species.
If this estimate of Ka/Ks is (significantly) smaller than
the Ka/Ks estimate of fixed differences along the species
lineage, positive selection can be inferred (McDonald
1991).
Unfortunately, other genetic changes in a gene (such
as insertions and deletions, changes in splicing pattern,
regulatory changes), can not currently be tested in a
similar way, mainly because a neutral mutation rate like
Ks is missing for these kinds of changes so that expected
values can not rigorously be estimated. Although single
adaptive genetic changes can in principle be identified
by their signature of selection at closely linked sites
within a population, this signature vanishes quickly after
the selected site has been fixed in a population, so that
for example in humans such a signature is not expected
if the fixation of the adaptive mutation is more than
200,000 years ago (Przeworski 2002). The relative brain
size of modern humans was probably attained around
500,000 years ago (see above). Therefore, seeking the
signature of selection in this way does not seem a very
promising method by which to find human-specific
adaptive changes related to brain size increase.
Evolutionary Studies of Microcephalin
Two studies have examined the evolution of MCPH1,
and both find some evidence for positive selection (Evans
et al. 2004a; Wang and Su 2004). In the study by Wang
and Su, a signature of positive selection on the lineage
leading from the ancestor of all apes to the ancestor of
great apes was found, as well as some signature of pos-
itive selection during recent human evolution (i.e., very
likely less than half a million years ago). In the study
by Evans et al., a signature of positive selection on the
lineages leading to the ancestor of Old World Monkeys,
apes, great apes, African apes, and finally humans was
found. Given the relatively low power to detect positive
selection at all, these findings are remarkable. However,
their results need to be viewed with caution, as the stron-
gest signatures of selection are detected on lineages,
which show no particular evidence for an increase in
encephalization, and the human lineage, for which the
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biggest change in brain size has occurred, does not show
a tendency for higher Ka/Ks compared with other lin-
eages. As discussed above, this does not exclude the pos-
sibility that some changes in Microcephalin might have
been positively selected which lead to the human brain
increase, but independent evidence for this (e.g., by func-
tional studies) is needed.
Evolutionary Studies of ASPM
The evolution of the ASPM gene in primates and
mammals has been examined in three studies (Zhang
2003; Evans et al. 2004b; Kouprina et al. 2004). An
initial and tempting speculation that the number of IQ
repeats (74 in man, 62 in mouse, and 24 in Drosophila)
could correlate with brain size in animals could not be
confirmed, since many mammals have as many IQ re-
peats as humans and since the difference in IQ length
between mouse and human is specific for the lineage
leading to mouse (Bond et al. 2002; Zhang 2003). In-
terestingly, however, the highest Ka/Ks ratio is found on
the human lineage, and analyses of polymorphisms
among humans suggest that ASPM is currently under a
high evolutionary constraint, indicating that human-spe-
cific amino acid changes might have been fixed by pos-
itive selection. As for Microcephalin, these findings are
remarkable in the light of the relatively low power of
these tests, and this time the biggest increase in Ka/Ks
correlates with the biggest increase in brain size. How-
ever, high Ka/Ks values have also been found on other
ape lineages, and polymorphisms in gorillas suggest that
amino acid changes in ASPM might already have been
fixed by positive selection in the ancestors of humans,
chimpanzees, and gorillas (Kouprina et al. 2004). Ad-
ditionally, the high Ka/Ks ratio on the human lineage
seems to be caused, to a large extent, by a lower number
of fixed synonymous substitutions. This would imply a
lower mutation rate on the human lineage, in addition
to positive selection. So some aspects of these evolu-
tionary findings do not have a straightforward interpre-
tation for human brain expansion.
Implications of Evolutionary Findings
Although the signatures of positive selection for
ASPM and for Microcephalin are not so strong that they
clearly implicate a role for these genes in human brain
expansion, they have an encouraging tendency. Further
evolutionary analyses of other primate or mammalian
lineages in which increases in relative brain size occurred
(see above) might be fruitful, to clarify how well evo-
lutionary changes in MCPH genes correlate with brain
size increase. In addition, the identification of genes that
interact with MCPH genes, especially in neuronal pro-
genitor cell mitosis, will lead to further candidates that
might be involved in the evolution of brain size increase
in humans and other species. It is worth noting that an
increase in relative brain size is not the only phenotypic
change that occurred during the evolution of the human
brain (Preuss 2004) and that recent studies suggest that
positive selection might have acted on a considerable
number of genes important for brain function and de-
velopment during human evolution (Dorus et al. 2004).
It will be important (and difficult) to find functional
model systems in which these kinds of evolutionary hy-
potheses can be further tested. Transgenic mice could be
one such possibility, and, although it is unclear to what
extent mice would work as a model system in this re-
spect, it is encouraging that artificial genetic changes can
cause a brain size increase in mice (Chenn and Walsh
2002).
Conclusions
Given the many possible causes of microcephaly, the
diagnosis of MCPH should only be made after differ-
ential diagnoses have been sought and eliminated. With
identification of MCPH genes, the following are becom-
ing increasingly available for patients: prenatal diagnosis
(to detect a recurrence of the disorder), postnatal di-
agnosis (to distinguish the disorder from the many dif-
ferential diagnoses), and carrier testing (in consanguin-
eous families in which the disease is known to occur).
There are at least seven genes that can cause this neu-
rodevelopmental disorder; four have been identified, and
current evidence suggests that MCPH is probably a pri-
mary disorder of neurogenic mitosis. As such, it may
have much to teach us about the control of neuron pro-
duction by neural stem cells and about how this has
been modulated by evolution to control the brain sizes
of different species.
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